News
Public · Published
Datavault hits Nasdaq deadline 68% below $1 as extension or delisting decision looms
Datavault, whose ticker is DVLT, faces a Nasdaq deadline because its share price is 68% below the $1 minimum. Its first cure period ends August 24, and a further 180-day extension depends on meeting other listing tests and receiving a written split notice.
Published:
Updated:
What happened
Datavault, whose ticker is DVLT, faces a Nasdaq deadline because its share price is 68% below the $1 minimum. Its first cure period ends August 24, and a further 180-day extension depends on meeting other listing tests and receiving a written split notice.
Confirmed
Global impact / market context
If Datavault cannot raise its share price to $1, it risks being removed from Nasdaq, which could make its stock harder to trade and reduce investor confidence, possibly hurting its ability to raise borrowed money for business growth.
Analyst inference
This news focuses only on Datavault's compliance challenge. For investors, a stock under $1 often signals financial distress, and the deadline creates uncertainty about the company's future, making its shares riskier than those of companies comfortably above the minimum price.
Analyst inference
What to watch
- Watch whether Datavault meets the other listing tests by August 24, because failing them would end the current cure period and lead to a delisting decision. Confirmed
- Investors should consider that Datavault might attempt a reverse stock split, which is a method to boost share price, though it does not improve the company's real financial health. Proposed
- If delisting happens, expect reduced trading activity and potential price drops, as institutional investors often avoid stocks that are no longer on major exchanges like Nasdaq. Analyst inference